Applied Therapeutics (APLT)
(Real Time Quote from BATS)
$0.47 USD
0.00 (0.00%)
Updated Aug 5, 2025 09:38 AM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Applied Therapeutics Inc. has a market cap of $66.54M, which represents its share price of $0.47 multiplied by its outstanding shares number of 141.58M. As a small-cap company, APLT's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
APLT 0.47 0.00(0.00%)
Will APLT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for APLT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APLT
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Lags Revenue Estimates
Sangamo Therapeutics (SGMO) Reports Q4 Loss, Misses Revenue Estimates
APLT: What are Zacks experts saying now?
Zacks Private Portfolio Services
BeiGene (ONC) Soars 3.2%: Is Further Upside Left in the Stock?
Company News for Dec 2, 2024
Biotech Stock Roundup: BBIO Stock Up on Drug Approval, SAVA, APLT Plunge on Setbacks & More
Other News for APLT
Applied Therapeutics Announces New Chief Medical Officer
APLT Announces Key Executive Promotions | APLT Stock News
Applied Therapeutics Announces Key Leadership Appointments | APLT Stock News
Applied Therapeutics CMO Riccardo Perfetti to depart, Evan Bailey to succeed
Applied Therapeutics CMO Riccardo Perfetti to depart, Evan Bailey to succeed